Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Jul 7;6(3):89-90.
doi: 10.14744/hf.2025.2025.0055. eCollection 2025.

Non-invasive tests fail to ensure therapeutic precision for resmetirom in MASLD

Gupse Adali  1 , Remzi Adnan Akdogan  2
Affiliations
Editorial

Non-invasive tests fail to ensure therapeutic precision for resmetirom in MASLD

Gupse Adali et al. Hepatol Forum. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to declare.

References

    1. Le P, Kaya E, Phan A, Yilmaz Y, Alkhouri N. Resmetirom-eligible population among US adults: An estimation analysis based on NHANES 2017-March 2020. Hepatol Commun. 2025;9:e0755. doi: 10.1097/HC9.0000000000000755. - DOI - PMC - PubMed
    1. Kaya E, Aksoy S, Oruc N, Tasdemir C, Cengiz BI, Keklikkiran C, et al. Hepatol Forum: 2025. Non-invasive tests for resmetirom treatment fail to accurately define the target population: Evidence from a biopsy-proven MASLD cohort. - DOI
    1. Harrison SA, Taub R, Neff GW, Lucas KJ, Labriola D, Moussa SE, et al. Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial. Nat Med. 2023;29(11):2919–2928. doi: 10.1038/s41591-023-02603-1. - DOI - PMC - PubMed
    1. Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, et al. The changing prevalence of non-alcoholic fatty liver disease (NAFLD) in Turkey in the last decade. Turk J Gastroenterol. 2021;32(3):302–312. doi: 10.5152/tjg.2021.20062. - DOI - PMC - PubMed
    1. Değertekin B, Tozun N, Demir F, Söylemez G, Parkan Ş, Gürtay E, et al. The Changing Prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) in Turkey in the Last Decade. Turk J Gastroenterol. 2021;32(3):302–312. doi: 10.5152/tjg.2021.20062. - DOI - PMC - PubMed

Publication types

LinkOut - more resources